The story of Viagra presents a complex picture for shareholders. While the initial launch generated massive profits, the end of its exclusive rights opened the door to off-brand versions, dramatically reducing sales. https://onelifesocial.com/story7097842/sildenafil-and-the-pharmaceutical-industry-a-risky-investment